Altmetric

Antimicrobial stewardship: are we failing in cross-specialty clinical engagement?

File Description SizeFormat 
JAC Antimicrobial Stewardship Manuscript revison 050915.docxAccepted version336.05 kBMicrosoft WordView/Open
Title: Antimicrobial stewardship: are we failing in cross-specialty clinical engagement?
Authors: Rawson, TM
Moore, LSP
Gilchrist, MJ
Holmes, AH
Item Type: Journal Article
Abstract: Background Antimicrobial resistance (AMR) is a public health priority and leading patient safety issue. Globally, antimicrobial stewardship (AMS) has been integral in promoting therapeutic optimization whilst minimizing harmful antimicrobial use. A cross-sectional, observational study was undertaken to investigate the coverage of AMS and antibacterial resistance across clinical scientific conferences in 2014, as a surrogate marker for current awareness and attributed importance. Methods Clinical specialties were identified, and the largest corresponding clinical scientific/research conferences in 2014 determined (i) within the UK and (ii) internationally. Conference characteristics and abstracts were interrogated and analysed to determine those related to AMS and AMR. Inter-specialty variation was assessed using χ2 or Fisher's exact statistical analysis. Results In total, 45 conferences from 23 specialties were analysed representing 59 682 accepted abstracts. The UK had a significantly greater proportion of AMS-AMR-related abstracts compared with international conferences [2.8% (n = 221/7843) compared with 1.8% (n = 942/51 839); P < 0.001]. Infection conferences contained the greatest proportion of AMS-AMR abstracts, representing 20% (732/3669) of all abstracts [UK 66% (80/121) and international 18% (652/3548); P < 0.0001]. AMS-AMR coverage across all general specialties was poor [intensive care 9% (116/1287), surgical 1% (8/757) and medical specialties 0.64% (332/51 497)] despite high usage of antimicrobials across all. Conclusions Despite current AMS-AMR strategies being advocated by infection specialists and discussed by national and international policy makers, AMS-AMR coverage remained limited across clinical specialty scientific conferences in 2014. We call for further intervention to ensure specialty engagement with AMS programmes and promote the AMR agenda across clinical practice.
Issue Date: 23-Oct-2015
Date of Acceptance: 18-Sep-2015
URI: http://hdl.handle.net/10044/1/42325
DOI: http://dx.doi.org/10.1093/jac/dkv337
ISSN: 1460-2091
Publisher: Oxford University Press
Start Page: 554
End Page: 559
Journal / Book Title: Journal of Antimicrobial Chemotherapy
Volume: 71
Issue: 2
Copyright Statement: © 2016 Oxford University Press. This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The definitive publisher-authenticated version is available online at: http://dx.doi.org/10.1093/jac/dkv337.
Sponsor/Funder: National Institute for Health Research
National Institute for Health Research
National Institute of Health Research Imperial Biomedical Research Centre
NIHR Invention for Innovation
Funder's Grant Number: HPRU-2012-10047
II-LA-0214-20008
WMNF_P46472
II-LA-0214-20008
Keywords: Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
Microbiology
Pharmacology & Pharmacy
CARE
PROGRAM
Microbiology
1115 Pharmacology And Pharmaceutical Sciences
0605 Microbiology
1108 Medical Microbiology
Publication Status: Published
Appears in Collections:Department of Medicine
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx